Overview

• Mexico’s Health Ministry opened the 2025–2026 Winter Vaccination Campaign (Oct 13–Apr 3) with goals of 35.4 million flu, 10.9 million COVID-19 and 4.2 million pneumococcal doses, now available across public clinics.
• The COVID-19 rollout uses monovalent mRNA shots Spikevax LP.8.1 (Moderna) and Comirnaty LP.8.1 (Pfizer/BioNTech), with Moderna already supplying 4.8 million updated doses.
• Priority recipients include children 6–59 months, people 5–59 with risk conditions, pregnant women, health workers and all adults 60+, with cautions for prior myocarditis and no pneumococcal vaccine in pregnancy.
• Local brigades in places like Carmen, Campeche are taking vaccines to markets, schools and neighborhoods to boost uptake among at-risk groups.
• In Spain, Madrid begins combined flu and COVID vaccination targeting 1.6 million people with 1.68 million flu doses including 70,000 intranasal vials for ages 2–5, while Galicia pilots school intranasal flu shots and Andalusia reports near-70% coverage in under-fives.